Financials · mywealthgrid

Loading page…

Annual Quarterly

Consolidated Standalone

Consolidated figures · ₹ crore

₹ Cr	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
	5,893	6,006	7,465	9,111	9,154	6,099	6,059	6,282	6,703	7,235	8,280
COGS	2,117	2,000	2,869	3,522	3,141	1,536	1,488	1,878	2,141	2,317	2,644
Gross profit	3,776	4,007	4,596	5,589	6,014	4,563	4,571	4,404	4,562	4,918	5,635
	2,529	2,953	3,171	4,221	4,067	3,155	3,496	3,615	3,637	3,744	4,376
	1,247	1,054	1,425	1,368	1,947	1,408	1,075	789	925	1,173	1,260
OPM %	21.2%	17.6%	19.1%	15%	21.3%	23.1%	17.8%	12.6%	13.8%	16.2%	15.2%
Depreciation	347	—	415	—	462	349	382	554	382	369	440
Interest	371	341	284	220	287	184	145	188	272	240	212
	13	25	133	316	13	258	82	-18	-100	416	7
Profit before tax	542	738	859	904	1,211	1,133	630	28	171	981	614
Tax	155	163	225	327	312	297	217	93	98	144	217
Tax %	28.7%	22.1%	26.2%	36.2%	25.8%	26.2%	34.5%	333.6%	57.4%	14.7%	35.3%
	387	575	634	577	898	836	413	-65	73	836	398
PAT margin %	6.6%	9.6%	8.5%	6.3%	9.8%	13.7%	6.8%	-1%	1.1%	11.6%	4.8%
EPS (₹)	25.1	36.9	41.3	36.9	56.4	52.5	26	-3.8	4.9	53	25.2
EPS adjusted (₹)	25.4	37	40.7	36.1	56.4	52.5	26	-3.8	4.9	53.1	25.2
	12%	8.1%	7.3%	12.2%	8.9%	9.5%	19.2%	—	102.7%	9.4%	19.9%
Annual report	Annual report for Mar 2016	Annual report for Mar 2017	Annual report for Mar 2018	Annual report for Mar 2019	Annual report for Mar 2020	Annual report for Mar 2021	Annual report for Mar 2022	Annual report for Mar 2023	Annual report for Mar 2024	Annual report for Mar 2025	Annual report for Mar 2026

₹ Cr	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Equity capital	15	16	16	16	16	16	16	16	16	16	16
Reserves	2,510	3,420	4,071	4,793	5,588	4,726	5,303	5,383	5,418	6,239	7,077
Minority interest	—	—	—	0	—	0	—	—	—	—	3
	4,223	3,761	3,293	4,743	4,390	2,584	2,928	3,410	3,414	2,437	3,220
	1,787	1,844	2,238	1,917	2,528	1,593	1,745	2,347	2,701	4,065	5,208
Total equity & liabilities	8,536	9,041	9,618	11,469	12,522	8,918	9,991	11,157	11,549	12,756	15,523
	4,921	5,107	5,401	5,648	6,067	4,319	4,573	5,183	4,814	4,855	6,533
CWIP	198	211	300	492	264	278	292	773	1,252	2,715	2,962
Investments	114	103	124	115	69	241	239	256	42	44	61
	3,303	3,621	3,793	5,213	6,122	4,080	4,888	4,944	5,440	5,144	5,966
Total assets	8,536	9,041	9,618	11,469	12,522	8,918	9,991	11,157	11,549	12,756	15,523

Segment results

As reported in NSE results XBRL. Segment result is before tax and finance costs. ROCE uses that annual result divided by segment assets less liabilities.

Source XBRL ↗

Latest reported period · 31 Mar 2026 · ₹ crore

Segment	Revenue	Result	Assets	Liabilities	Capital employed	ROCE %
Radiopharma	3,690.1	359.9	3,679.2	1,239.4	2,439.8	14.75
Contract Development and Manufacturing Organisation - Sterile Injectables	1,812.6	206.3

₹ Cr	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
	1,099	1,268	1,303	1,122	1,543	1,482	838	661	971	1,072	1,227
	-313	-450	-618	-1,012	-327	721	-380	-544	-608	488	-1,260
	-843	-686	-901	657	-1,050	3,453	-33	-157	-433	-1,453	95
Net cash flow	-52	117	-212	761	225	5,656	425	-40	-69	107	62
Free cash flow	1,099	1,268	1,303	1,122	—	955	238	-154	74	-44	-222
CFO / Operating profit %	88.1%	120.4%	91.4%	82%	79.2%	106.2%	77.2%	85.1%	107.8%	91.3%	97.4%